| Tag | Content |
|---|
EnhancerAtlas ID | HS141-10234 |
Organism | Homo sapiens |
Tissue/cell | NB4 |
Coordinate | chr2:65158670-65159470 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr2:65159295-65159313 | CCTGCCTCCCATTCTTCC | - | 6.23 | | RREB1 | MA0073.1 | chr2:65158832-65158852 | TCCCCAAACACCCCCACCCC | + | 7.63 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_11451 | chr2:65154008-65167948 | CD20 | | SE_32517 | chr2:65155067-65162588 | GM12878 | | SE_43549 | chr2:65157276-65162765 | MM1S | | SE_59110 | chr2:65140204-65174657 | Ly3 | | SE_60487 | chr2:65131740-65174567 | DHL6 | | SE_61232 | chr2:65140276-65174682 | HBL1 | | SE_61920 | chr2:65131130-65179624 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I064928 | chr2 | 65155352 | 65162612 |
|
Enhancer Sequence | TTCTCTCCTT TCATTCTCAT CCCTCCTCTC TTGCTGAATT ATTATCCAAA ATACAAAAGA 60
ACAAACTCAC AGACTGGTAG GAACCTACAT CTTTAATCCT AACCCCCGTT ACCTGCTTTG 120
GATATCCAAC ACTCTAACCA AATAGGCTTA ATTAAATATG ATTCCCCAAA CACCCCCACC 180
CCAGGTGTCT CAGTCACTCT GTGCTGTTAT AAATGACTAT ATACTGGGTG GCTTAGACAA 240
CAGAGATTTA TTTCTCACTG TTCTAGAGGC CGGGAAGTCA GATCAGGGCG CCAGCATGGT 300
CGGCTCTGGT AAGGGACCTC TTCCTCGTTT GCAGATGACC ATTCTCTCGT TGTGTCCTCA 360
CATGGCAGAG AGGATAGAAA GCAAGCTCTC TCCTGTCTTT TCATGAAGAC ACTAATCCCA 420
TTCATGAGGG ATTCACCCTC ATGGCCTAAT TACTTTCCAG AGGCCACACC ACCTAATGCC 480
ATCACAATGG GGACTGGGCT TCAACAAGTC GATTAGGGGG AAGGGGGGAG CCACAAGCAT 540
CCAGTCCATA GTACCAGGCT CTCATATCTC AGGCCTCTGT TCCTGGTCTT CTCCTTCCCT 600
GAATTTTCTC TCCCTTTGCA GCCTGCCTGC CTCCCATTCT TCCTTTCAGA CCTTCCTTTG 660
AAGCAACCTT GTCTAGGAAG GCTTTGCAAC CTGAACTCTT CCTCCTTAGA TATTTATAGC 720
TCTTTGAGCT CCTCTATTAA TTATAACAAG GTAGTAAGTG ACAGAACATC TGACACCAGA 780
TGGCTCAAAC AAACGAAAAG 800
|
